Actively Recruiting
Randomized Trial of Turmeric to Treat Basal Joint Arthritis in Adults 40 and Older
Led by Massachusetts General Hospital · Updated on 2025-11-24
60
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a pilot randomized controlled trial to evaluate whether turmeric, a commercially available dietary supplement, can help manage pain and stiffness in patients with basal joint arthritis, specifically thumb osteoarthritis. The study aims to assess changes in pain intensity and disability related to this condition. This trial is supported by Massachusetts General Hospital and focuses on adults aged 40 and older who experience basal joint pain with specific clinical signs and radiographic evidence. Participants are randomly assigned to one of two groups. One group receives turmeric pastilles 100 mg three times daily for six weeks, while the other group receives a placebo pill with the same schedule. The study uses a quadruple masking approach to ensure unbiased results. Both groups follow the treatment for six weeks to compare the effects of turmeric against placebo. During the study, participants are evaluated at enrollment, after six weeks of treatment, and again at three months. Researchers will measure changes in baseline pain intensity and disability using standardized assessments. Participants are monitored for adherence to the treatment schedule and any changes in symptoms. The total study duration includes the treatment and follow-up periods to assess lasting effects and safety.
CONDITIONS
Brief Title
Turmeric for Patients With Basal Joint Arthritis
Research Team
N
Neal Chen, M.D.
K
Karan Amin, BA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here